Tag:

South Korea

Latest Headlines

Latest Headlines

Hanmi licenses poziotinib to U.S-based Spectrum outside of China, South Korea

Hanmi Pharmaceutical has licensed its poziotinib for treating several types of cancer to U.S.-based Spectrum Pharmaceuticals.

South Korea pregnancy test kit and contraceptive sales firm up after adultery law struck down

Several South Korea drug and medical-device makers can expect to be the big winners from a Constitutional Court ruling striking down the nation's law making adultery a federal crime. The law was passed in 1953 to protect women.

Generic, biosimilar revenues look solid in Asia with many Indian firms eyeing innovation

Various recent reports covering the near-term and long-term outlook for the pharmaceutical industry in Asia paint a positive picture with increased revenues coming from the generics and biosimilars industries along with products as specific as human insulin from China.

CrystalGenomics joins Daewoong to commercialize Acelex in South Korea

CrystalGenomics signed a sales and marketing deal with South Korea's Daewoong Pharmaceutical for the commercialization of Acelex (polmacoxib), granting the South Korean firm exclusive rights in country for the osteoarthritis treatment.

South Korea lifts ban on zilpaterol feed additives in beef

Almost a year after saying it would ease its policy on animal growth enhancers containing zilpaterol, the South Korean government lifted its ban on the feed additive. The move opens the door to beef imports and domestic sales of the product.

Bristol-Myers inks Asia immunotherapy deal with Japan's Ono

In a deal that will build on their existing mutual relationship, Bristol-Myers Squibb and Ono Pharmaceutical have formed a pact to bring immunotherapies to market in Japan, South Korea and Taiwan.

Korean pharma booster recruits Novotech to boost local R&D

Novotech, which bills itself as Australia's largest CRO, has signed a deal with a South Korean outfit to help bolster the country's status among global drug development locales.

Bristol-Myers extends manufacturing pact with Samsung

Bristol-Myers Squibb hooked up with South Korea's Samsung last year when it wanted someone to handle manufacturing overseas for its hot-selling melanoma drug Yervoy. But with more promising biologics in its pipeline, the New York-based drugmaker has decided to deepen its commitment.

South Korea targets medical device industry as its latest growth engine

Business Korea reported that the government has a goal for its med tech industry to export more than $12.5 billion worth of goods, hire 130,000 people and have a 3.8% global market share by 2020.

Sanofi inks a Korean alliance to develop a pneumococcal vaccine

The French Big Pharma is paying SK Chemicals $23 million up front, after which both companies will invest in the project.